Inventage Lab, Inc. (KOSDAQ:389470)
South Korea · Delayed Price · Currency is KRW 29,200
+3,400 (13.18%)
At close: Oct 1, 2026
Inventage Lab Market Cap
Inventage Lab has a market cap or net worth of 388.59 billion as of October 1, 2026. Its market cap has decreased by -22.25% in one year.
Market Cap
388.59B
Enterprise Value
330.36B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
29,200.00
ChartMarket Cap Chart
Since November 22, 2022, Inventage Lab's market cap has increased from 122.67B to 388.59B, an increase of 216.77%. That is a compound annual growth rate of 34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 388.59B | -63.04% |
| Dec 30, 2025 | 1.05T | 391.67% |
| Dec 30, 2024 | 213.83B | 45.37% |
| Dec 28, 2023 | 147.09B | 83.30% |
| Dec 29, 2022 | 80.25B | -34.58% |
| Nov 22, 2022 | 122.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 555.69B |
| ROKIT Healthcare | 462.76B |
| Curocell | 329.67B |
| HansBiomed | 295.92B |
| Genome & Company | 266.73B |
| IntoCell | 260.48B |
| S.Biomedics | 258.23B |
| IMBiologics | 244.36B |